Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

A Korean Family with Cholesterol Ester Transfer Protein Deficiency

  • Youn, Seo-Young (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Shin, Ik-Soon (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Hong, Yong-Hee (Department of Pediatrics, Seoul Seong Ae Hospital) ;
  • Lee, Dong-Hwan (Department of Pediatrics, College of Medicine, Soonchunhyang University)
  • Received : 2012.06.03
  • Accepted : 2012.06.21
  • Published : 2012.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

A 32-year-old female patient and her sister show high levels of high density lipoprotein (HDL) cholesterol in regular health checkups, since female patient was 11 years old. The patient's serum total cholesterol was 285 mg/dL and HDL cholesterol was 113 mg/dL. Her sister's total cholesterol was 240 mg/dL and the HDL cholesterol measured to be 90 mg/dL. Lipoprotein pattern and cholesteryl ester transfer activity gene analysis were examined in these patients. We found c.1321+1G>A (IVS14+1G/A) hetero mutation in cholesteryl ester transfer protein (CETP) genes. Generally, CETP mediates transfer and exchange of triglycerides and cholesteryl ester between plasma lipoproteins. Also we investigated a key role of HDL-CE and Apo A-1 metabolism. Patients with low levels of CETP have increased serum HDL levels. We hereby report two Korean cases of CETP deficiency in a family. Brief literature review ensues with the cases.

Keywords

References

  1. Alan R. The Effects of Cholesterol Ester Transfer Protein Inhibition on Cholesterol Efflux. Am J Cardiol 2009;104:39-45.
  2. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989;342:448-51. https://doi.org/10.1038/342448a0
  3. Barkowski RS, Frishman WH. HDL metabolism and CETP inhibition. Cardiol rev 2008;16:154-62. https://doi.org/10.1097/CRD.0b013e31816a3b60
  4. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events. N Engl J Med 2007;357:1301-10. https://doi.org/10.1056/NEJMoa064278
  5. Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M, et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japan. J Atheroscler Thromb 2004;11:110-21. https://doi.org/10.5551/jat.11.110
  6. Nagano M, Yamashita S, Hirano K, Ito M, Maruyama T, Ishihara M, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay. J Lipid Res 2002;43:1011-8. https://doi.org/10.1194/jlr.M200024-JLR200
  7. Kurasawa T, Yokoyama S, Miyake Y, Yamamura T, Yamamoto A. Rate of Cholesteryl Ester Transfer between high and low density lipoproteins in human serum and case with decreased transfer rate in association with hyperalphalipoproteinemia. J Biochem, 1985;98:1499-508. https://doi.org/10.1093/oxfordjournals.jbchem.a135418
  8. Koizumi J, Mabuchi H, Yoshimura A, Michishita I, Takeda M, Itoh H, et al. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia. Atherosclerosis 1985;58:175- https://doi.org/10.1016/0021-9150(85)90064-4
  9. Ai M, Tanaka A, Shimokado K, Ohtani R, Inazu A, Kobayashi J, et al. A deficiency of cholesteryl ester transfer protein whose serum remnant- like particle-triglyceride significantly increased, but serum remnant- like particle-cholesterol did not after an oral fat load. Ann Clin Biochem 2009;46:457-63. https://doi.org/10.1258/acb.2009.008249
  10. H. Bryan Brewer. Increasing HDL Cholesterol Levels. N Eng J Med 2004; 350:1491-4. https://doi.org/10.1056/NEJMp048023
  11. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 2004;44:720-32. https://doi.org/10.1016/j.jacc.2004.07.001
  12. Teh EM, Dolphin PJ, Breckenridge WC, Tan MH. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America. J Lipid Res 1998;39: 442-56.
  13. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, et al. Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity. Arterioscler Thromb Vasc Biol 1997;17:1053-9. https://doi.org/10.1161/01.ATV.17.6.1053
  14. Moriyama Y, Okamura T, Inazu A, Doi M, Iso H, Mouri Y, et al. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev Med 1998;27:659- https://doi.org/10.1006/pmed.1998.0340
  15. Bisgaier CL, Siebenkas MV, Brown ML, Inazu A, Koizumi J, Mabuchi H, et al. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. J Lipid Res 1991; 32:21-33.
  16. Barter P, Rye KA. The Effects of Cholester Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now. Trends Pharmacol Sci 2011;32:694-9. https://doi.org/10.1016/j.tips.2011.07.004
  17. Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004;45:948-53. https://doi.org/10.1194/jlr.M300520-JLR200
  18. Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, et al. Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women The Prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk Population Study. Circulation 2004;110:1418-23. https://doi.org/10.1161/01.CIR.0000141730.65972.95
  19. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased Coronary Heart Disease in Japanese-American Men with Mutation in the Cholesteryl Ester Transfer Protein Gene Despite Increased HDL Levels. J Clin Invest 1996;97:2917-23. https://doi.org/10.1172/JCI118751
  20. Nagano M, Nakamura M, Kobayashi N, Kamata J, Hiramori K. Effort Angina in a Middle-Aged Woman With Abnormally High Levels of Serum High-Density Lipoprotein Cholesterol- A Case of Cholesteryl-Ester Transfer Protein Deficiency. Circ J 2005;69:609-12. https://doi.org/10.1253/circj.69.609
  21. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79:8-15. https://doi.org/10.1161/01.CIR.79.1.8